Status:
UNKNOWN
Spray vs EMLA Cream on Pain During Intra-articular Injection
Lead Sponsor:
Soonchunhyang University Hospital
Conditions:
Adhesive Capsulitis of the Shoulder
Eligibility:
All Genders
19-70 years
Phase:
PHASE4
Brief Summary
All participants are randomly allocated to the spray group, EMLA group and placebo group. In spray group, participants receive an application of placebo cream at the needle electrode insertion site 60...
Detailed Description
All participants are randomly allocated to the spray group, EMLA group and placebo group. In spray group, participants receive an application of placebo cream at the needle electrode insertion site 6...
Eligibility Criteria
Inclusion
- Who had a normative schedule of intra-articular injection of shoulder
Exclusion
- those who refused to participate, those who were unable to understand a visual analog scale or a Likert scale, those with a history of an allergic reaction to vapocoolant spray or lidocaine, those with a history of cold intolerance (eg, Raynaud syndrome), those who took pain medications or had used topical anesthetics within the previous 24 hours, those with prior history of intra-articular injection of shoulder, those who exhibited an abnormal shoulder sensation on neurologic examination
Key Trial Info
Start Date :
March 14 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 19 2020
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT03484832
Start Date
March 14 2018
End Date
May 19 2020
Last Update
April 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Soonchunhyang University Hospital, Bucheon
Bucheon-si, Gyeonggido, South Korea, 420767